SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001199835-23-000109
Filing Date
2023-02-21
Accepted
2023-02-17 20:14:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 OUTLOOK THERAPEUTICS, INC./JASON HOPE SCHEDULE 13G/A, AMENDMENT NO. 1 schedule_13g.htm SC 13G/A 29501
  Complete submission text file 0001199835-23-000109.txt   30883
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-89495 | Film No.: 23644887
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7150 E CAMELBACK ROAD #444 SCOTTSDALE AZ 85251
Business Address
Hope Jason (Filed by) CIK: 0001920983 (see all company filings)

Type: SC 13G/A